Integrin beta 7 antibody
Quick Overview for Integrin beta 7 antibody (ABIN371134)
Target
See all Integrin beta 7 (ITGB7) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- This antibody is specific to mouse LPAM1 (Integrin alpha 4 beta 7). It recognises a conformational epitope on the heterodimer.
-
Characteristics
- Synonyms: Integrin alpha-4/beta-7, Integrin alpha 4, Integrin beta 7, ITGA4, ITGB7, LPAM1, CD49d,VLA-4, Lymphocyte Peyer PatchAdhesion Molecule
-
Endotoxin Level
- Low Endotoxin
-
Immunogen
- AKR/Cum mouse spontaneous T lymphoma cell line TK1. (Ref. 1)
-
Isotype
- IgG2a
-
-
-
-
Application Notes
-
Flow Cytometry. (Ref.1-4)Immunohistochemistry on Frozen Sections. (Ref.3)Induction of homotypic cellular aggregation. Blockade of binding to cell adhesion molecules.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS containing no preservatives.
-
Preservative
- Without preservative
-
Storage
- -20 °C
-
Storage Comment
-
Store the antibody undiluted in (aliquots) at -20 °C. Avoid repeated freezing and thawing.
Shelf life: one year from despatch. -
Expiry Date
- 12 months
-
-
- Integrin beta 7 (ITGB7)
-
Alternative Name
- Integrin beta-7
-
Background
- The lymphocyte Peyer's patch adhesion molecule (LPAM-1), also known as Integrin alpha 4 beta 7 is a member of the integrin family of cell surface receptors. It is expressed primarily on mucosal lymphocytes, but is also present on NK cells and eosinophils. The alpha 4 beta 7 heterodimer mediates the binding of lymphocytes to its ligand, mucosal vascular addressin (MAdCAM1) on the high endothelial venules, thereby directing the homing of lymphocytes into Peyer's patches and intestinal lamina propria. (Ref.1-4)Synonyms: Adhesion Molecule, CD49d, ITGA4, ITGB7, Integrin alpha 4, Integrin alpha-4/beta-7, Integrin beta 7, LPAM1, Lymphocyte Peyer Patch, VLA-4
-
Gene ID
- 16421
-
UniProt
- P26011
-
Pathways
- Integrin Complex
Target
-